Abstract
Anthrax toxin is one of two major virulence factors secreted by pathogenic Bacillus anthracis, the etiologic agent of anthrax. Because inhalational anthrax is highly fatal, the agent has been weaponized for biowarfare and bioterrorism. Anthrax toxin is comprised of three individually nontoxic proteins, protective antigen (PA), lethal factor (LF), and edema factor (EF). But, to physiologically function, these individual subunits assemble into potent cytotoxins containing PA plus LF and/or EF. The PA component oligomerizes into a heptamer or octamer, which can insert into a host cell membrane to form a protein translocase channel. Under a transmembrane proton gradient driving force, LF and EF translocate through the narrow PA channel into the cytosol of the host cell. The narrowness of the channel necessitates that LF and EF unfold during translocation. This channel is unusual in this respect, because it contains its own unfoldase and translocase machinery. Highly nonspecific and dynamic clamp sites in the PA channel catalyze these activities. Anthrax toxin has been used extensively as a biophysical model to interrogate the molecular basis of translocation-coupled unfolding and translocation. It is being actively targeted by therapeutics to inhibit its function. New biotechnological adaptations use the toxin as a cancer therapy and generalized protein delivery vehicle.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arora N, Leppla SH (1993) Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 268:3334–3341
Ashiuchi M, Nawa C, Kamei T et al (2001) Physiological and biochemical characteristics of poly gamma-glutamate synthetase complex of Bacillus subtilis. Eur J Biochem FEBS 268:5321–5328
Astumian RD (1997) Thermodynamics and kinetics of a Brownian motor. Science 276:917–922
Aubin-Tam ME, Olivares AO, Sauer RT et al (2011) Single-molecule protein unfolding and translocation by an ATP-fueled proteolytic machine. Cell 145:257–267. doi:10.1016/j.cell.2011.03.036, S0092-8674(11)00313-8 [pii]
Baldari CT, Tonello F, Paccani SR, Montecucco C (2006) Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol 27:434–440. doi:10.1016/j.it.2006.07.002
Bann JG (2012) Anthrax toxin protective antigen-Insights into molecular switching from prepore to pore. Protein Sci 21:1–12. doi:10.1002/pro.752
Barth H, Aktories K, Popoff MR, Stiles BG (2004) Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 68:373–402
Basilio D, Jennings-Antipov LD, Jakes KS, Finkelstein A (2011a) Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins. J Gen Physiol 137:343–356. doi:10.1085/jgp.201010578, jgp.201010578 [pii]
Basilio D, Juris SJ, Collier RJ, Finkelstein A (2009) Evidence for a proton-protein symport mechanism in the anthrax toxin channel. J Gen Physiol 133:307–314
Basilio D, Kienker PK, Briggs SW, Finkelstein A (2011b) A kinetic analysis of protein transport through the anthrax toxin channel. J Gen Physiol 137:521–531. doi:10.1085/jgp.201110627, jgp.201110627 [pii]
Bell SE, Mavila A, Salazar R et al (2001) Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 114:2755–2773
Belton FC, Strange RE (1954) Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br J Exp Pathol 35:144–152
Benson EL, Huynh PD, Finkelstein A, Collier RJ (1998) Identification of residues lining the anthrax protective antigen channel. Biochemistry 37:3941–3948
Beyer W, Turnbull PCB (2009) Anthrax in animals. Mol Aspects Med 30:481–489. doi:10.1016/j.mam.2009.08.004
Bezrukov SM, Liu X, Karginov VA et al (2012) Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins. Biophys J 103:1208–1217. doi:10.1016/j.bpj.2012.07.050
Blanke SR, Milne JC, Benson EL, Collier RJ (1996) Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen. Proc Natl Acad Sci U S A 93:8437–8442
Blaustein RO, Finkelstein A (1990) Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Effects on macroscopic conductance. J Gen Physiol 96:905–919
Blaustein RO, Koehler TM, Collier RJ, Finkelstein A (1989) Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc Natl Acad Sci U S A 86:2209–2213
Blaustein RO, Lea EJ, Finkelstein A (1990) Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Single-channel analysis. J Gen Physiol 96:921–942
Boyer AE, Quinn CP, Hoffmaster AR et al (2009) Kinetics of lethal factor and poly-d-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect Immun 77:3432–3441. doi:10.1128/IAI.00346-09, IAI.00346-09 [pii]
Bradley KA, Mogridge J, Mourez M et al (2001) Identification of the cellular receptor for anthrax toxin. Nature 414:225–229
Brown MJ, Thoren KL, Krantz BA (2011) Charge requirements for proton gradient-driven translocation of anthrax toxin. J Biol Chem 286:23189–23199. doi:10.1074/jbc.M111.231167, M111.231167 [pii]
Bruckner V, Kovacs J, Denes G (1953) Structure of poly-d-glutamic acid isolated from capsulated strains of B. anthracis. Nature 172:508
Burton RE, Siddiqui SM, Kim YI et al (2001) Effects of protein stability and structure on substrate processing by the ClpXP unfolding and degradation machine. EMBO J 20:3092–3100
Candela T, Fouet A (2005) Bacillus anthracis CapD, belonging to the γ-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol Microbiol 57:717–726
Candela T, Fouet A (2006) Poly-gamma-glutamate in bacteria. Mol Microbiol 60:1091–1098. doi:10.1111/j.1365-2958.2006.05179.x
Candela T, Mock M, Fouet A (2005) CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis. J Bacteriol 187:7765–7772. doi:10.1128/JB.187.22.7765-7772.2005
Chauwin JF, Oster G, Glick BS (1998) Strong precursor-pore interactions constrain models for mitochondrial protein import. Biophys J 74:1732–1743
Chavarría-Smith J, Vance RE (2013) Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog 9, e1003452. doi:10.1371/journal.ppat.1003452
Christensen KA, Krantz BA, Melnyk RA, Collier RJ (2005) Interaction of the 20 kDa and 63 kDa fragments of anthrax protective antigen: kinetics and thermodynamics. Biochemistry 44:1047–1053. doi:10.1021/bi047791s
Collier RJ (2009) Membrane translocation by anthrax toxin. Mol Aspects Med 30:413–422. doi:10.1016/j.mam.2009.06.003, S0098-2997(09)00035-1 [pii]
Collier RJ, Young JA (2003) Anthrax toxin. Annu Rev Cell Dev Biol 19:45–70
Crampton N, Brockwell DJ (2010) Unravelling the design principles for single protein mechanical strength. Curr Opin Struct Biol 20:508–517. doi:10.1016/j.sbi.2010.05.005, S0959-440X(10)00075-8 [pii]
Cunningham K, Lacy DB, Mogridge J, Collier RJ (2002) Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A 99:7049–7053
Gill DM (1978) Seven toxic peptides that cross cell membranes. In: Jeljaszewicz J, Wadstrom T (eds) Bacterial Toxins and Cell Membranes. Academic, New York, pp 291–332
Dmochewitz L, Lillich M, Kaiser E et al (2011) Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen. Cell Microbiol 13:359–373. doi:10.1111/j.1462-5822.2010.01539.x
Drum CL, Yan SZ, Bard J et al (2002) Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396–402
Duesbery NS, Webb CP, Leppla SH et al (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734–737
Dumetz F, Jouvion G, Khun H et al (2011) Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol 178:2523–2535. doi:10.1016/j.ajpath.2011.02.027
Evans AS (1976) Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 49:175–195
Ezzell JW, Abshire TG (1992) Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol 138:543–549
Ezzell JW, Abshire TG, Panchal R et al (2009) Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun 77:749–755. doi:10.1128/IAI.00764-08, IAI.00764-08 [pii]
Feld GK, Brown MJ, Krantz BA (2012a) Ratcheting up protein translocation with anthrax toxin. Protein Sci 21:606–624. doi:10.1002/pro.2052
Feld GK, Kintzer AF, Tang II et al (2012b) Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen. J Mol Biol 415:159–174. doi:10.1016/j.jmb.2011.10.035, S0022-2836(11)01172-7 [pii]
Feld GK, Thoren KL, Kintzer AF et al (2010) Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers. Nat Struct Mol Biol 17:1383–1390. doi:10.1038/nsmb.1923, nsmb.1923 [pii]
Feller W (2008) An introduction to probability theory and its applications. Wiley, Hoboken
Fersht AR (1998) Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding. Freeman, New York
Finkelstein A (2009) Proton-coupled protein transport through the anthrax toxin channel. Philos Trans R Soc Lond B Biol Sci 364:209–215. doi:10.1098/rstb.2008.0126, 74702356P024100L [pii]
Floyd DL, Ragains JR, Skehel JJ et al (2008) Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105:15382–15387. doi:10.1073/pnas.0807771105
Frankel AE, Kuo S-R, Dostal D et al (2009) Pathophysiology of anthrax. Front Biosci Landmark Ed 14:4516–4524
Friedlander AM (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 261:7123–7126
Friedlander AM, Pittman PR, Parker GW (1999) Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282:2104–2106
Fu S, Tong X, Cai C et al (2010) The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. PLoS One 5, e11203. doi:10.1371/journal.pone.0011203
Glick BS (1995) Can Hsp70 proteins act as force-generating motors? Cell 80:11–14
Green BD, Battisti L, Koehler TM et al (1985) Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun 49:291–297
Gu LQ, Braha O, Conlan S et al (1999) Stochastic sensing of organic analytes by a pore-forming protein containing a molecular adapter. Nature 398:686–690
Halverson KM, Panchal RG, Nguyen TL et al (2005) Anthrax biosensor: protective antigen ion channel asymmetric blockade. J Biol Chem 280:34056–34062
Hanks S, Adams S, Douglas J et al (2003) Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73:791–800
Huang S, Ratliff KS, Schwartz MP et al (1999) Mitochondria unfold precursor proteins by unraveling them from their N-termini. Nat Struct Biol 6:1132–1138
Jang J, Cho M, Chun JH et al (2011) The poly-γ-d-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity. Infect Immun 79:3846–3854. doi:10.1128/IAI.01145-10, IAI.01145-10 [pii]
Janowiak BE, Finkelstein A, Collier RJ (2009) An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen. Protein Sci 18:348–358. doi:10.1002/pro.35
Jernigan DB, Raghunathan PL, Bell BP et al (2002) Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 8:1019–1028. doi:10.3201/eid0810.020353
Juris SJ, Melnyk RA, Bolcome RE et al (2007) Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin. Infect Immun 75:5052–5058. doi:10.1128/IAI.00490-07, IAI.00490-07 [pii]
Karginov VA, Nestorovich EM, Moayeri M et al (2005) Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. Proc Natl Acad Sci U S A 102:15075–15080. doi:10.1073/pnas.0507488102
Katayama H, Janowiak BE, Brzozowski M et al (2008) GroEL as a molecular scaffold for structural analysis of the anthrax toxin pore. Nat Struct Mol Biol 15:754–760. doi:10.1038/nsmb.1442, nsmb.1442 [pii]
Katayama H, Wang J, Tama F et al (2010) Three-dimensional structure of the anthrax toxin pore inserted into lipid nanodiscs and lipid vesicles. Proc Natl Acad Sci U S A 107:3453–3457
Kenniston JA, Baker TA, Fernandez JM, Sauer RT (2003) Linkage between ATP consumption and mechanical unfolding during the protein processing reactions of an AAA+ degradation machine. Cell 114:511–520
Kintzer AF, Sterling HJ, Tang II et al (2010a) Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism. PLoS One 5, e13888
Kintzer AF, Sterling HJ, Tang II et al (2010b) Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J Mol Biol 399:741–758. doi:10.1016/j.jmb.2010.04.041, S0022-2836(10)00429-8 [pii]
Kintzer AF, Tang II, Schawel AK et al (2012) Anthrax toxin protective antigen integrates poly-γ-d-glutamate and pH signals to sense the optimal environment for channel formation. Proc Natl Acad Sci U S A 109:18378–18383. doi:10.1073/pnas.1208280109, 1208280109 [pii]
Kintzer AF, Thoren KL, Sterling HJ et al (2009) The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol 392:614–629. doi:10.1016/j.jmb.2009.07.037, S0022-2836(09)00876-6 [pii]
Klimpel KR, Molloy SS, Thomas G, Leppla SH (1992) Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A 89:10277–10281
Koehler TM (2009) Bacillus anthracis physiology and genetics. Mol Aspects Med 30:386–396. doi:10.1016/j.mam.2009.07.004, S0098-2997(09)00052-1 [pii]
Kofoed EM, Vance RE (2011) Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477:592–595. doi:10.1038/nature10394, nature10394 [pii]
Krantz BA, Finkelstein A, Collier RJ (2006) Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient. J Mol Biol 355:968–979
Krantz BA, Melnyk RA, Zhang S et al (2005) A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science 309:777–781
Krantz BA, Trivedi AD, Cunningham K et al (2004) Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin. J Mol Biol 344:739–756
Lacy DB, Lin HC, Melnyk RA et al (2005) A model of anthrax toxin lethal factor bound to protective antigen. Proc Natl Acad Sci U S A 102:16409–16414
Lacy DB, Mourez M, Fouassier A, Collier RJ (2002) Mapping the anthrax protective antigen binding site on the lethal and edema factors. J Biol Chem 277:3006–3010
Lacy DB, Wigelsworth DJ, Melnyk RA et al (2004a) Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A 101:13147–13151
Lacy DB, Wigelsworth DJ, Scobie HM et al (2004b) Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc Natl Acad Sci U S A 101:6367–6372. doi:10.1073/pnas.0401506101 [doi] 0401506101 [pii]
Leppla SH (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A 79:3162–3166
Levinsohn JL, Newman ZL, Hellmich KA et al (2012) Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog 8:e1002638. doi:10.1371/journal.ppat.1002638, PPATHOGENS-D-12-00046 [pii]
Liao X, Rabideau AE, Pentelute BL (2014) Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigen. Chembiochem 15:2458–2466. doi:10.1002/cbic.201402290
Liu S, Crown D, Miller-Randolph S et al (2009) Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A 106:12424–12429. doi:10.1073/pnas.0905409106
Maillard RA, Chistol G, Sen M et al (2011) ClpX(P) generates mechanical force to unfold and translocate its protein substrates. Cell 145:459–469. doi:10.1016/j.cell.2011.04.010, S0092-8674(11)00429-6 [pii]
Martchenko M, Jeong S-Y, Cohen SN (2010) Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci U S A 107:15583–15588. doi:10.1073/pnas.1010145107
Mayor A (2008) Greek fire, poison arrows, and scorpion bombs: biological & chemical warfare in the ancient world. Overlook Press, New York
McCluskey AJ, Collier RJ (2013) Receptor-directed chimeric toxins created by sortase-mediated protein fusion. Mol Cancer Ther 12:2273–2281. doi:10.1158/1535-7163.MCT-13-0358
Meador WE, Means AR, Quiocho FA (1992) Target enzyme recognition by calmodulin: 2.4 a structure of a calmodulin-peptide complex. Science 257:1251–1255
Meador WE, Means AR, Quiocho FA (1993) Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science 262:1718–1721
Melnyk RA, Collier RJ (2006) A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation. Proc Natl Acad Sci U S A 103:9802–9807. doi:10.1073/pnas.0604000103, 0604000103 [pii]
Melnyk RA, Hewitt KM, Lacy DB et al (2006) Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen. J Biol Chem 281:1630–1635
Mikesell P, Ivins BE, Ristroph JD, Dreier TM (1983) Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun 39:371–376
Miller CJ, Elliott JL, Collier RJ (1999) Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38:10432–10441
Milne JC, Blanke SR, Hanna PC, Collier RJ (1995) Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol Microbiol 15:661–666
Milne JC, Furlong D, Hanna PC et al (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem 269:20607–20612
Moayeri M, Leppla SH (2009) Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 30:439–455. doi:10.1016/j.mam.2009.07.003, S0098-2997(09)00051-X [pii]
Moayeri M, Wiggins JF, Leppla SH (2007) Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun 75:5175–5184. doi:10.1128/IAI.00719-07, IAI.00719-07 [pii]
Mock M, Fouet A (2001) Anthrax. Annu Rev Microbiol 55:647–671
Mogridge J, Cunningham K, Collier RJ (2002a) Stoichiometry of anthrax toxin complexes. Biochemistry 41:1079–1082
Mogridge J, Cunningham K, Lacy DB et al (2002b) The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A 99:7045–7048
Mogridge J, Mourez M, Collier RJ (2001) Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J Bacteriol 183:2111–2116
Molloy SS, Bresnahan PA, Leppla SH et al (1992) Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267:16396–16402
Mourez M, Yan M, Lacy DB et al (2003) Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc Natl Acad Sci U S A 100:13803–13808
Mueller P, Rudin DO, Tien HT, Westcott WC (1963) Methods for the formation of single bimolecular lipid membranes in aqueous solution. J Phys Chem 67:534–535
Nanda A, Carson-Walter EB, Seaman S et al (2004) TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res 64:817–820
Nassi S, Collier RJ, Finkelstein A (2002) PA63 channel of anthrax toxin: an extended β-barrel. Biochemistry 41:1445–1450
Nestorovich EM, Bezrukov SM (2014) Designing inhibitors of anthrax toxin. Expert Opin Drug Discov 9:299–318. doi:10.1517/17460441.2014.877884
Nguyen TL (2004) Three-dimensional model of the pore form of anthrax protective antigen. Structure and biological implications. J Biomol Struct Dyn 22:253–265
Oomen CJ, Van Ulsen P, Van Gelder P et al (2004) Structure of the translocator domain of a bacterial autotransporter. EMBO J 23:1257–1266
Orlik F, Schiffler B, Benz R (2005) Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis. Biophys J 88:1715–1724
Panchal RG, Halverson KM, Ribot W et al (2005) Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem 280:10834–10839. doi:10.1074/jbc.M412210200
Pannifer AD, Wong TY, Schwarzenbacher R et al (2001) Crystal structure of the anthrax lethal factor. Nature 414:229–233
Pentelute BL, Barker AP, Janowiak BE et al (2010) A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor. ACS Chem Biol 5:359–364. doi:10.1021/cb100003r
Pentelute BL, Sharma O, Collier RJ (2011) Chemical dissection of protein translocation through the anthrax toxin pore. Angew Chem Int Ed Engl 50:2294–2296. doi:10.1002/anie.201006460
Petosa C, Collier RJ, Klimpel KR et al (1997) Crystal structure of the anthrax toxin protective antigen. Nature 385:833–838
Pflughoeft KJ, Swick MC, Engler DA et al (2014) Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease. J Bacteriol 196:424–435. doi:10.1128/JB.00690-13
Phillips DD, Fattah RJ, Crown D et al (2013) Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors. J Biol Chem 288:9058–9065. doi:10.1074/jbc.M113.452110
Pittman PR, Kim-Ahn G, Pifat DY et al (2002) Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 20:1412–1420
Quinn CP, Singh Y, Klimpel KR, Leppla SH (1991) Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J Biol Chem 266:20124–20130
Rasko DA, Worsham PL, Abshire TG et al (2011) Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proc Natl Acad Sci U S A 108:5027–5032. doi:10.1073/pnas.1016657108, 1016657108 [pii]
Ratts R, Trujillo C, Bharti A et al (2005) A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol. Proc Natl Acad Sci U S A 102:15635–15640. doi:10.1073/pnas.0504937102, 0504937102 [pii]
Ratts R, Zeng H, Berg EA et al (2003) The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 160:1139–1150. doi:10.1083/jcb.200210028, jcb.200210028 [pii]
Ryan PL, Young JA (2008) Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. PLoS One 3:e1817. doi:10.1371/journal.pone.0001817
Santelli E, Bankston LA, Leppla SH, Liddington RC (2004) Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature 430:905–908
Schueler-Furman O, Wang C, Baker D (2005) Progress in protein-protein docking: atomic resolution predictions in the CAPRI experiment using RosettaDock with an improved treatment of side-chain flexibility. Proteins 60:187–194. doi:10.1002/prot.20556
Scobie HM, Rainey GJ, Bradley KA, Young JA (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A 100:5170–5174. doi:10.1073/pnas.0431098100, 0431098100 [pii]
Sellman BR, Mourez M, Collier RJ (2001a) Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science 292:695–697
Sellman BR, Nassi S, Collier RJ (2001b) Point mutations in anthrax protective antigen that block translocation. J Biol Chem 276:8371–8376
Sharma O, Collier RJ (2014) Polylysine-mediated translocation of the diphtheria toxin catalytic domain through the anthrax protective antigen pore. Biochemistry 53:6934–6940. doi:10.1021/bi500985v
Shaw CA, Starnbach MN (2008) Antigen delivered by anthrax lethal toxin induces the development of memory CD8+ T cells that can be rapidly boosted and display effector functions. Infect Immun 76:1214–1222. doi:10.1128/IAI.01208-07
Shen Y, Zhukovskaya NL, Guo Q et al (2005) Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor. EMBO J 24:929–941
Simon SM, Peskin CS, Oster GF (1992) What drives the translocation of proteins? Proc Natl Acad Sci U S A 89:3770–3774
Singh Y, Klimpel KR, Goel S et al (1999) Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun 67:1853–1859
Smith H, Keppie J (1954) Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 173:689
Song L, Hobaugh MR, Shustak C et al (1996) Structure of staphylococcal α-hemolysin, a heptameric transmembrane pore. Science 274:1859–1866
Sterne M (1939) The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Ondersteport J Vet Sci Anim Indust 13:307–312
Strange RE, Belton FC (1954) Studies on a protective antigen produced in vitro from Bacillus anthracis: purification and chemistry of the antigen. Br J Exp Pathol 35:153–165
Sun J, Lang AE, Aktories K, Collier RJ (2008) Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation. Proc Natl Acad Sci U S A 105:4346–4351. doi:10.1073/pnas.0800701105, 0800701105 [pii]
Sun J, Vernier G, Wigelsworth DJ, Collier RJ (2007) Insertion of anthrax protective antigen into liposomal membranes: effects of a receptor. J Biol Chem 282:1059–1065
Tamayo AG, Bharti A, Trujillo C et al (2008) COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro. Proc Natl Acad Sci U S A 105:5254–5259. doi:10.1073/pnas.0710100105, 0710100105 [pii]
Thoren KL, Krantz BA (2011) The unfolding story of anthrax toxin translocation. Mol Microbiol 80:588–595. doi:10.1111/j.1365-2958.2011.07614.x
Thoren KL, Worden EJ, Yassif JM, Krantz BA (2009) Lethal factor unfolding is the most force-dependent step of anthrax toxin translocation. Proc Natl Acad Sci U S A 106:21555–21560. doi:10.1073/pnas.0905880106, 0905880106 [pii]
Turnbull PC (1991) Anthrax vaccines: past, present and future. Vaccine 9:533–539
Turnbull PCB (1996) Bacillus Medical Microbiology. University of Texas Medical Branch at Galveston, Galveston
Uchida I, Makino S, Sasakawa C et al (1993) Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol Microbiol 9:487–496
Uchida I, Sekizaki T, Hashimoto K, Terakado N (1985) Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J Gen Microbiol 131:363–367
Van der Goot G, Young JA (2009) Receptors of anthrax toxin and cell entry. Mol Aspects Med 30:406–412. doi:10.1016/j.mam.2009.08.007, S0098-2997(09)00059-4 [pii]
Vitale G, Bernardi L, Napolitani G et al (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352:739–745
Von Moltke J, Trinidad NJ, Moayeri M et al (2012) Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490:107–111. doi:10.1038/nature11351
Wasserman GM, Grabenstein JD, Pittman PR et al (2003) Analysis of adverse events after anthrax immunization in US Army medical personnel. J Occup Environ Med Am Coll Occup Environ Med 45:222–233
Wein AN, Liu S, Zhang Y et al (2013) Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel. Invest New Drugs 31:206–212. doi:10.1007/s10637-012-9847-1
Wei W, Lu Q, Chaudry GJ et al (2006) The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124:1141–1154. doi:10.1016/j.cell.2005.12.045, S0092-8674(06)00199-1 [pii]
Wesche J, Elliott JL, Falnes PO et al (1998) Characterization of membrane translocation by anthrax protective antigen. Biochemistry 37:15737–15746
Wigelsworth DJ, Krantz BA, Christensen KA et al (2004) Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem 279:23349–23356
Williams P, Wallace D (1989) Unit 731: Japan’s secret biological warfare in World War II. Free Press, New York
Wimalasena DS, Cramer JC, Janowiak BE et al (2007) Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation. Biochemistry 46:14928–14936. doi:10.1021/bi701763z
Wolfe JT, Krantz BA, Rainey GJ et al (2005) Whole-cell voltage clamp measurements of anthrax toxin pore current. J Biol Chem 280:39417–39422
Wright GG, Hedberg MA, Slein JB (1954) Studies on immunity in anthrax. III. Elaboration of protective antigen in a chemically defined, non-protein medium. J Immunol 72:263–269
Wynia-Smith SL, Brown MJ, Chirichella G et al (2012) Electrostatic ratchet in the protective antigen channel promotes anthrax toxin translocation. J Biol Chem 287:43753–43764. doi:10.1074/jbc.M112.419598, M112.419598 [pii]
Young JA, Collier RJ (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76:243–265. doi:10.1146/annurev.biochem.75.103004.142728
Young JJ, Bromberg-White JL, Zylstra C et al (2007) LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog 3, e27. doi:10.1371/journal.ppat.0030027, 07-PLPA-RA-0017 [pii]
Zhang S, Finkelstein A, Collier RJ (2004a) Evidence that translocation of anthrax toxin’s lethal factor is initiated by entry of its N terminus into the protective antigen channel. Proc Natl Acad Sci U S A 101:16756–16761
Zhang S, Udho E, Wu Z et al (2004b) Protein translocation through anthrax toxin channels formed in planar lipid bilayers. Biophys J 87:3842–3849
Zhao Y, Yang J, Shi J et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600. doi:10.1038/nature10510
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Krantz, B.A. (2015). Anthrax Toxin Protective Antigen Forms an Unusual Channel That Unfolds and Translocates Proteins Across Membranes. In: Delcour, A.H. (eds) Electrophysiology of Unconventional Channels and Pores. Springer Series in Biophysics, vol 18. Springer, Cham. https://doi.org/10.1007/978-3-319-20149-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-20149-8_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20148-1
Online ISBN: 978-3-319-20149-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)